Global Asthma Network Phase I study in Mexico: prevalence of asthma symptoms, risk factors and altitude associations—a cross-sectional study

Author:

Del-Río-Navarro Blanca Estela,Berber Arturo,Reyes-Noriega NayelyORCID,Navarrete-Rodríguez Elsy Maureen,García-Almaraz Roberto,Ellwood Philippa,Garcia-Marcos Luis,Saucedo-Ramírez Omar Josué,Mérida-Palacio Valente Juan,Ramos-García Beatriz Del Carmen,Escalante-Domínguez Alberto José,Linares-Zapién Francisco Javier,Moreno-Gardea Héctor Leonardo,Ochoa-López Georgina,Hernández-Mondragón Luis Octavio,Lozano-Sáenz José Santos,Sacre-Hazouri José Antonio,Juan-Pineda Ángeles,Sánchez-Coronel Ma Guadalupe,Rodríguez-Pérez Noel,Ambriz-Moreno María de Jesús

Abstract

BackgroundGlobal Asthma Network (GAN) was established in 2012 as a development to the International Study of Asthma and Allergies in Childhood to improve asthma care globally.ObjectiveTo survey asthma, allergic rhinitis and atopic dermatitis in primary and secondary school children and to investigate and evaluate its prevalence, severity, management and risk factors in Mexico.MethodsGAN Phase I is a cross-sectional, multicentre survey carried out in 15 centres corresponding to 14 Mexican cities throughout 2016–2019 using the validated Spanish language version of the GAN Phase I questionnaires. The questionnaires were completed by parents of 6–7-year-old primary school pupils (school children) and by 13–14-year-old adolescents.ResultsA total of 35 780 school children and 41 399 adolescents participated. Wheezing ever prevalence was 26.2% (95% CI 25.8% to 26.7%) in school children and 23.9% (95% CI 23.4% to 24.3%) in adolescents. The corresponding frequencies for current wheeze were 10.2% (95% CI 9.9% to 10.5%) and 11.6% (95% CI 11.2% to 11.9%). In school children, the risk factors for current wheeze were rhinitis (OR 4.484; 95% CI 3.915% to 5.134%) and rash symptoms (OR 1.735; 95% CI 1.461% to 2.059%). For adolescents, rhinitis symptoms (OR 3.492; 95% CI 3.188% to 3.825%) and allergic rhinitis diagnosis (OR 2.144; 95% CI 1.787% to 2.572%) were the most significant. For both groups, there was a negative relation with centres’ sea level altitude higher than 1500 m above mean sea level (p<0.005).ConclusionsThe most important risk factors for asthma symptoms in both age groups were the presence of rhinitis and rash symptoms or diagnosis. On the other hand, sea level altitude higher than 1500 metres was a protective factor.

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference44 articles.

1. The Union . The global asthma report 2018. Auckland, New Zealand: Global Asthma Network, 2018.

2. Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control

3. Asher MI , Strachan DP , Pearce N , et al . The Isaac story: the International study of asthma and allergies in childhood. Auckland, New Zealand: The International Study of Asthma and Allergies in Childhood, 2011.

4. The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3